Clinical trial Recruiting at 1 site Interventional Ages 12 to 17

Cognitive-behavioral therapy for Chinese adolescents with self-injury

Official title: A Blended Version of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Chinese Adolescents With Non-suicidal Self-injury: A Pilot Study

Run by Central South University · NCT06858540 · Data updated 2026-11-12

This study is testing a new online and video therapy program to help Chinese teens aged 12-17 who hurt themselves learn to manage their emotions better.

Quick facts

Study typeInterventional
Ages12 Years to 17 Years
SexAll
Enrollment12 (estimated)
SponsorCentral South University
Academic / other
Locations1 site (Changsha, Hunan)
StatusRecruiting
StartedApril 29, 2025
Main results expectedOctober 30, 2025
Study endsOctober 30, 2025
Registry record updatedMay 4, 2025
Trial IDNCT06858540 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Chinese adolescents aged 12-17 who have engaged in non-suicidal self-injury at least 5 times in the past year.

Probably not a fit

Patients who have attempted suicide recently or have serious mental health disorders may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention utilizes the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A) to help Chinese adolescents aged 12-17 who engage in non-suicidal self-injury (NSSI). The program consists of 8 modules, including both online self-guided sessions and therapist-guided videoconference sessions, aimed at teaching participants how to manage their emotional distress more effectively. The study will evaluate the feasibility, acceptability, and preliminary efficacy of this blended treatment approach through pretest, posttest, and follow-up assessments.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce self-injury behaviors and improve emotional regulation in adolescents.

How similar studies have gone: Other studies utilizing cognitive-behavioral therapy for emotional disorders have shown promising results, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged between 12 and 17 years;
2. Engaged in non-suicidal self-injury (NSSI) at least 5 times in the past 12 months, with at least 1 episode in the past month;
3. Minimum education level of primary school or above;
4. Participant and guardian fully understand the research content and agree to participate, with signed informed consent provided.

Exclusion Criteria:

1. Suicide attempts in the past month or a score of ≥17 on the MINI National Neuropsychiatric Interview for Children (MINI KID 5.0), indicating a high risk of suicide;
2. Diagnosis of a psychotic disorder, manic or hypomanic episode, autism spectrum disorder, or other serious neurodevelopmental disorders according to the DSM-5;
3. Presence of severe physical illness or other medical conditions that may affect the completion of treatment and evaluation;
4. Currently receiving other professional psychotherapy or participating in another NSSI intervention study;
5. Received 5 or more sessions of cognitive behavioral therapy (CBT) in the past 5 years;
6. Having received electroconvulsive therapy (ECT) within the past 6 months.

Where it's running

  • The Second Xiangya Hospital
    Changsha, Hunan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.